Código QR (código de barras bidimensional)

Serum Immunoglobulin Changes in Multiple Myeloma Patients Treated with CAR T-Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising treatment for relapsed or refractory multiple myeloma (RRMM), with high response rates of 80–95%. Serum immunoglobulin changes have been observed throughout conventional multiple myeloma treatment, including after immunomodula...

ver descrição completa

Na minha lista:
Principais autores: Alexa Burger, Ulrike Bacher, Michele Hoffmann, Katja Seipel, Christof Schild, Inna Shaforostova, Thomas Pabst
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2025-08-01
coleção:Current Issues in Molecular Biology
Assuntos:
multiple myeloma (MM)
CAR T-cell therapy
isotype switching
immuno-fixation electrophoresis (IFE)
Acesso em linha:https://www.mdpi.com/1467-3045/47/8/640
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados